Recruiting

Observational Study

Sponsor:

Power Life Sciences Inc.

Code:

NCT05881356

Conditions

OCD

Obsessive-Compulsive Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.

Conditions

OCD

Obsessive-Compulsive Disorder

Study ID

NCT05881356

Start date

Jun, 2024

Status verified date

May, 2023

Completion date

Jun, 2026

Anticipated

Primary completion date

Jun, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
  • Participant has a diagnosis of OCD.
  • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria:

  • Pregnant or lactating woman
  • Enrolled in another research study
  • Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Rate of participants who decide to enroll in a OCD clinical study. [ Time Frame: 3 months ]
  • Number of OCD patients who remain in clinical trial until completion. [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Michael B Gill

415-900-4227bask@withpower.com

Locations

Power Life Sciences

Recruiting

San Francisco, California, United States, 94107

Contacts

Michael B Gill

415-900-4227https://www.withpower.com/contact-us@withpower.com

More Information

Sponsor

Power Life Sciences Inc.

Last update posted

May 31, 2023

Last verified

May, 2023

Keywords

  • OCD
  • Obsessive-Compulsive Disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Power Life Sciences Inc. on 2023-05-31.